Filter
1740
Text search:
Clinical
documentation
Featured
Recommendations
158
New Publications
479
Language
Document type
No document type
1007
Guidelines
272
Studies & Reports
192
Manuals
134
Strategic & Response Plan
66
Training Material
36
Fact sheets
17
Situation Updates
9
Resource Platforms
3
Brochures
2
Infographics
1
Online Courses
1
Countries / Regions
India
110
Kenya
66
Western and Central Europe
65
Uganda
55
Global
46
Ethiopia
45
South Africa
41
Liberia
40
Nigeria
34
Tanzania
31
Malawi
31
Sierra Leone
30
Ghana
30
Rwanda
30
Zambia
29
Eastern Europe
28
Nepal
27
Bangladesh
26
Ukraine
22
Congo, Democratic Republic of
21
Africa
21
Namibia
18
Myanmar / Burma
17
Lesotho
16
South Sudan
15
Syria
15
Botswana
14
Philippines
13
Latin America and the Carribbean
12
Guinea
11
Zimbabwe
11
South–East Asia Region
10
Eastern Europe and Central Asia
10
Haiti
8
Asia
8
Senegal
7
Cambodia
7
Mozambique
7
West and Central Africa
7
Venezuela
7
Burkina Faso
6
Germany
6
Eswatini/ Swaziland
6
Cameroon
5
Thailand
5
Colombia
5
East and Southern Africa
5
Côte d’Ivoire / Ivory Coast
4
USA
4
Indonesia
4
Sudan
4
Benin
4
Brazil
4
North Macedonia
4
Middle East and North Africa
4
Russia
4
Vietnam
4
Mali
3
Afghanistan
3
Chad
3
Angola
3
Yemen
3
Albania
3
Laos
3
Moldova
3
Georgia
3
France
3
United Kingdom
3
Pakistan
2
Lebanon
2
Turkey
2
China
2
Central African Republic
2
Argentina
2
Peru
2
Ecuador
2
Bolivia
2
Sri Lanka
2
Chile
2
Western Pacific Region
2
Bhutan
2
Timor Leste/ East Timor
2
Tajikistan
2
Somalia
1
Jordan
1
Egypt
1
Singapore
1
Dominican Republic
1
Madagascar
1
Mexico
1
Paraguay
1
Fiji
1
Southern Africa
1
Estonia
1
Kyrgyzstan
1
Australia
1
Kazakhstan
1
Denmark
1
Portugal
1
Spain
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
724
Clinical Guidelines
159
Women & Child Health
103
Key Resources
94
Public Health
77
Pharmacy & Technologies
35
Capacity Building
33
Annual Report MEDBOX
1
Toolboxes
HIV
144
TB
124
Mental Health
121
COVID-19
90
Caregiver
76
Ebola & Marburg
59
AMR
52
Pharmacy
49
NTDs
41
Rapid Response
39
Conflict
38
2.0 Rapid Response
31
Refugee
26
Disability
25
Global Health Education
20
Planetary Health
17
NCDs
16
Malaria
16
Natural Hazards
14
Zika
11
Specific Hazards
10
Polio
9
Cholera
7
Social Ethics
7
Health Financing Toolbox
5
A case study from Bosnia and Herzegovina Eurasian Harm Reduction Network
The case study was prepared by Samir Ibisevic, President of PROI between March and June 2016 and edited by Graham Shaw.
EHRN is grateful to all who contributed to this document, especially: Dr. Serifa Godinjak, Chairperson
...
Member States have requested WHO policy guidance on how to facilitate the implementation of national AMS activities in an integrated and programmatic approach. This policy guidance responds to that demand from Member States and is anchored in public health guiding principles in the human health sect
...
The major neglected tropical diseases, Taenia solium taeniosis/cysticercosis and schistosomiasis caused by Schistosoma mansoni or S. haematobium are presumed to be widely distributed in Africa. Taenia solium taeniosis/ cysticercosis has been reported as an emerging disease in different regions of Af
...
On 9 February 2021, a first webinar entitled “Expanding our understanding of Post COVID-19 condition” was held under the auspices of WHO and in consultation with the International Severe Acute Respiratory and Emerging Infection Consortium(ISARIC), Global Research Collaboration for Infectious Dis
...
tep 1 Competencies have been designed to provide staff with the core skills required to care for a critically ill patient safely, whilst under supervision. It is expected that Step 1 competencies will be completed prior to commencing an academic critical care programme.
Steps 2 & 3 Competencies hav
...
Interim Assessement Report
The EMA review was started by the Agency’s Committee for Medicinal Products for Human Use (CHMP) to support decision-making by health authorities. This first interim report includes information on seven experimental medicines intended for the treatment of people infecte
...
The Democratic Republic of Timor-Leste has the highest TB incidence rate in the South East Asian Region - 498 per 100,000, which is the seventh highest in the world. In Timor-Leste TB is the eighth most common cause of death.
The salient observations are as follows:
In 2018, 487 (12.5%) of the
...
RMRP 2020 - Regional Refugee and Migrant Response Plan for Refugees and Migrants from Venezuela 2020
The Venezuelan refugee and migrant crisis is one of the biggest external displacement crises in the world today. The COVID-19 pandemic has compounded an already desperate situation for many refugees and migrants, as well as their hosts, sorely testing health and social welfare systems and the abilit
...
Best practices” are exemplary public health practices that have achieved results, and which need to be scaled up so as to benefit more people. The expansion and institutionalization of successfully tested best practices requires strategic planning. There are several creative and constructive actio
...
This document updates recommendations for HIV testing by laboratories in the United States and offers approaches for reporting test results to persons ordering HIV tests and to public health authorities. The recommended algorithm is a sequence of tests used in combination to improve the accuracy of
...
The Global Antibiotic Resistance Partnership (GARP)-Mozambique team, in partnership with the Center for Disease Dynamics, Economics & Policy (CDDEP), has produced this report as part of a solid com-mitment to develop actionable policy proposals to tackle antibiotic resistance and improve appropriate
...
Integrated Management of pregnancy and childbirth
Improving the management of childhood tuberculosis within national tuberculosis programmes: research priorities based on a literature review
WHO/HTM/TB/2007.381, 07.02
Accessed: 26.10.2019
The extensive use of antimicrobials in human and veterinary medicine in recent years has accelerated the emergence and spread of resistant microorganisms. This situation has been worsened by the lack of investment in developing new effective antibiotics. The severity of the consequences is clear to
...
